1887
Volume 2022, Issue 3
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

The coronavirus disease (COVID-19) pandemic has had a significant worldwide impact since its emergence in 2019. End-stage kidney disease patients have been among the most vulnerable population affected and have a higher risk of acquiring infection and developing more severe disease. We have encountered three major COVID-19 waves in Qatar and they have required different strategies to overcome. The most recent wave was due to the Omicron variant characterized by higher transmissibility. The monthly incidence of COVID-19 infection during the Omicron wave in patients with end-stage renal disease peaked at 256 patients compared to 35 and 39 patients during the first and second waves, respectively. In addition, more than one-third of our dialysis staff became infected during this wave. Unlike the previous two waves, COVID-19 due to the Omicron variant was less severe with only 5% of hemodialysis patients requiring admission to the intensive care unit compared to 25% during the previous waves. The Omicron variant wave resulted in a crisis in our country due to the high number of non-hospitalized COVID-19 hemodialysis patients and the severe staff shortage. Several measures were taken to overcome the crisis, such as designating one facility to dialyze all COVID-19 ambulatory patients, reducing dialysis sessions to 3 hours, and introducing a fourth dialysis shift.

This article describes the challenges we faced in the ambulatory hemodialysis service during the Omicron wave and the measures taken in the COVID-19 and non-COVID-19 designated facilities to combat the crisis.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2022.38
2022-08-23
2022-10-04
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2022/3/qmj.2022.38.html?itemId=/content/journals/10.5339/qmj.2022.38&mimeType=html&fmt=ahah

References

  1. WHO coronavirus (COVID-19) Dashboard. https://covid19.who.int/, Accessed on 2022 June 22.
  2. Couchoud C, Bayer F, Ayav C, Béchade C, Brunet P, Chantrel F, et al; French REIN registry. Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients. Kidney Int. 2020 Dec; 98:(6):1519-1529. doi: 10.1016/j.kint.2020.07.042. Epub 2020 Aug 25. PMID: 32858081; PMCID: PMC7445552.
    [Google Scholar]
  3. Tarek Abdel Latif Ghonimi, Mohamad Mahmood Alkad, Essa Abdulla Abuhelaiqa, et al. Mortality and associated risk factors of COVID-19 infection in dialysis patients in Qatar: A nationwide cohort study, PLoS One. 2021, PMID: 34293004, PMCID: PMC8297751, DOI: 10.1371/journal.pone.0254246.
    [Google Scholar]
  4. Jager KJ, Kramer A, Chesnaye NC, et al. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe, Kidney Int. 2020, PMID: 32979369, PMCID: PMC7560263, DOI: 10.1016/j.kint.2020.09.006.
    [Google Scholar]
  5. Ng JH, Hirsch JS, Wanchoo R, et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020, PMID: 32810523, PMCID: PMC7428720, DOI: 10.1016/j.kint.2020.07.030.
    [Google Scholar]
  6. Basile C, Combe C, Pizzarelli F, Covic A, Davenport A, Kanbay M, et al. Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres. Nephrol Dial Transplant. 2020, PMID: 32196116, PMCID: PMC7184437, DOI: 10.1093/ndt/gfaa069.
    [Google Scholar]
  7. Kliger AS, Silberzweig J. Mitigating Risk of COVID-19 in Dialysis Facilities. Clin J Am Soc Nephrol. 2020, PMID: 32198130, PMCID: PMC7269225, DOI: 10.2215/CJN.03340320.
    [Google Scholar]
  8. Rombolà G, Heidempergher M, Pedrini L, Farina M, Aucella F, Messa P, et al. Practical indications for the prevention and management of SARS-CoV-2 in ambulatory dialysis patients: lessons from the first phase of the epidemics in Lombardy. J Nephrol. 2020, PMID: 32207068, PMCID: PMC7095015, DOI: 10.1007/s40620-020-00727-y.
    [Google Scholar]
  9. Goffin E, Candellier A, Vart P, Noordzij M, Arnol M, Covic A, et al. COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study. Nephrol Dial Transplant. 2021, PMID: 34132811, PMCID: PMC8394823, DOI: 10.1093/ndt/gfab200.
    [Google Scholar]
  10. Hsu CM, Weiner DE, Aweh G, Miskulin DC, Manley HJ, Stewart C, et al. COVID-19 Among US Dialysis Patients: Risk Factors and Outcomes From a National Dialysis Provider. Am J Kidney Dis. 2021, PMID: 33465417, PMCID: PMC7816961, DOI: 10.1053/j.ajkd.2021.01.003.
    [Google Scholar]
  11. Salerno S, Messana JM, Gremel GW, Dahlerus C, Hirth RA, Han P, et al. COVID-19 Risk Factors and Mortality Outcomes Among Medicare Patients Receiving Long-term Dialysis. JAMA Network Open. 2021, PMID: 34787655, PMCID: PMC8600389, DOI: 10.1001/jamanetworkopen.2021.35379.
    [Google Scholar]
  12. WHO. Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. 26 November 2021, https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern, Accessed on 2022 June 22.
  13. Khan NA, Al-Thani H, El-Menyar A. The emergence of new SARS-CoV-2 variant (Omicron) and increasing calls for COVID-19 vaccine boosters-The debate continues. Travel Med Infect Dis. 2022, PMID: 34942376, PMCID: PMC8687713, DOI: 10.1016/j.tmaid.2021.102246.
    [Google Scholar]
  14. Willyard C. What the Omicron wave is revealing about human immunity. Nature. 2022, PMID: 35110764, DOI: 10.1038/d41586-022-00214-3.
    [Google Scholar]
  15. Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022, PMID: 35042229, PMCID: PMC8942855, DOI: 10.1038/s41586-022-04411-y.
    [Google Scholar]
  16. MOPH Confirms Detection of Four Cases of Omicron COVID-19 Variant in Qatar. The peninsula news [press release] https://thepeninsulaqatar.com/article/17/12/2021/moph-announces-four-cases-of-omicron-variant-of-covid-19-in-qatar. Dec 2021.
  17. Planning and Statistics Authority. Monthly Figures on Total Population January 2022. https://www.psa.gov.qa/en/statistics1/StatisticsSite/pages/population.aspx .
    [Google Scholar]
  18. World Health Organization. STEPwise approach to chronic disease risk factor surveillance. Available from: https://www.who.int/ncds/surveillance/steps/qatar/en/.
    [Google Scholar]
  19. Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes 2012, PMID: 22737281, PMCID: PMC3382707, DOI: 10.4239/wjd.v3.i6.110.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2022.38
Loading
/content/journals/10.5339/qmj.2022.38
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): CoronavirusCOVID-19end-stage kidney diseasehemodialysisOmicron variant and Qatar
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error